Ignacio Aznar‐Lou

732 total citations
47 papers, 459 citations indexed

About

Ignacio Aznar‐Lou is a scholar working on Family Practice, Economics and Econometrics and Social Psychology. According to data from OpenAlex, Ignacio Aznar‐Lou has authored 47 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Family Practice, 16 papers in Economics and Econometrics and 12 papers in Social Psychology. Recurrent topics in Ignacio Aznar‐Lou's work include Medication Adherence and Compliance (16 papers), Health Systems, Economic Evaluations, Quality of Life (13 papers) and Mental Health Treatment and Access (11 papers). Ignacio Aznar‐Lou is often cited by papers focused on Medication Adherence and Compliance (16 papers), Health Systems, Economic Evaluations, Quality of Life (13 papers) and Mental Health Treatment and Access (11 papers). Ignacio Aznar‐Lou collaborates with scholars based in Spain, Australia and United States. Ignacio Aznar‐Lou's co-authors include María Rubio-Valera, Antoni Serrano‐Blanco, Ana Fernández, Maria Teresa Peñarrubia‐María, Juan V. Luciano, Joan Domènech‐Abella, Patrícia Moreno-Peral, T.G. van Tilburg, Daniel Fernández and Jordi Mundó and has published in prestigious journals such as PEDIATRICS, Nutrients and Journal of Affective Disorders.

In The Last Decade

Ignacio Aznar‐Lou

40 papers receiving 454 citations

Peers

Ignacio Aznar‐Lou
Siska Desplenter Belgium
Heather Smith United States
Anne Halli-Tierney United States
Kelly B. Haskard‐Zolnierek United States
Julia R. Liew United States
Linni Gu China
Papatya Karakurt Türkiye
C. I. Hasanah Malaysia
Confidence M. Gbarayor United States
Camille Cipri United States
Siska Desplenter Belgium
Ignacio Aznar‐Lou
Citations per year, relative to Ignacio Aznar‐Lou Ignacio Aznar‐Lou (= 1×) peers Siska Desplenter

Countries citing papers authored by Ignacio Aznar‐Lou

Since Specialization
Citations

This map shows the geographic impact of Ignacio Aznar‐Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignacio Aznar‐Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignacio Aznar‐Lou more than expected).

Fields of papers citing papers by Ignacio Aznar‐Lou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ignacio Aznar‐Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignacio Aznar‐Lou. The network helps show where Ignacio Aznar‐Lou may publish in the future.

Co-authorship network of co-authors of Ignacio Aznar‐Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Ignacio Aznar‐Lou. A scholar is included among the top collaborators of Ignacio Aznar‐Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ignacio Aznar‐Lou. Ignacio Aznar‐Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mucherino, Sara, Annunziata Raimondo, Ignacio Aznar‐Lou, et al.. (2025). Drug Utilization and Medication Adherence: A Data-Driven Analysis of Drugs with Different Routes of Administration Applied in Atopic Dermatitis. Pharmaceutics. 17(10). 1279–1279.
2.
3.
Cahir, Caitríona, Valéria Lima Passos, Kathleen Bennett, et al.. (2025). Identifying longitudinal medication adherence patterns of antipsychotic treatments: A real‐world cohort study in Catalonia, Spain. British Journal of Clinical Pharmacology. 91(6). 1790–1801. 1 indexed citations
4.
5.
Ribera, Aída, Ignacio Aznar‐Lou, John Slof, et al.. (2024). Costs during the first year after stroke by degree of functional disability: A societal perspective. European Stroke Journal. 10(2). 513–523.
6.
Aznar‐Lou, Ignacio, et al.. (2024). Cost-Effectiveness of a Multi-faceted Workplace Intervention to Reduce Musculoskeletal Pain in Nursing Staff: A Cluster-Randomized Controlled Trial (INTEVAL_Spain). Journal of Occupational Rehabilitation. 35(3). 602–614. 1 indexed citations
7.
Dima, Alexandra L., et al.. (2024). Evaluation of adherence to antipsychotics: A real‐world data study using four different dosing assumptions. British Journal of Clinical Pharmacology. 90(6). 1480–1492. 2 indexed citations
8.
Aznar‐Lou, Ignacio, et al.. (2023). Importance of Pharmacogenetics and Drug–Drug Interactions in a Kidney Transplanted Patient. Life. 13(8). 1627–1627. 4 indexed citations
9.
Vázquez, María Luisa, Íngrid Vargas, María Rubio-Valera, et al.. (2022). Improving equity in access to early diagnosis of cancer in different healthcare systems of Latin America: protocol for the EquityCancer-LA implementation-effectiveness hybrid study. BMJ Open. 12(12). e067439–e067439. 6 indexed citations
10.
11.
Aznar‐Lou, Ignacio, Luca Basile, Núria Soldevila, et al.. (2022). Costs and Factors Associated with Hospitalizations Due to Severe Influenza in Catalonia (2017–2020). International Journal of Environmental Research and Public Health. 19(22). 14793–14793. 3 indexed citations
12.
Aznar‐Lou, Ignacio, et al.. (2021). Use of Mental Health Services for Patients Diagnosed with Major Depressive Disorders in Primary Care. International Journal of Environmental Research and Public Health. 18(3). 885–885. 2 indexed citations
13.
Tonin, Fernanda S., et al.. (2021). Principles of pharmacoeconomic analysis: the case of pharmacist-led interventions. Pharmacy Practice. 19(1). 2302–2302. 20 indexed citations
14.
Aznar‐Lou, Ignacio, Maria Teresa Peñarrubia‐María, Patrícia Moreno-Peral, et al.. (2019). Reasons for medication non-initiation: A qualitative exploration of the patients’ perspective. Research in Social and Administrative Pharmacy. 16(5). 663–672. 18 indexed citations
15.
Aznar‐Lou, Ignacio, Antoni Serrano‐Blanco, Ana Fernández, et al.. (2017). Impact of initial medication non-adherence to SSRIs on medical visits and sick leaves. Journal of Affective Disorders. 226. 282–286. 10 indexed citations
16.
Serrano‐Blanco, Antoni, María Rubio-Valera, Ignacio Aznar‐Lou, et al.. (2017). In-patient costs of agitation and containment in a mental health catchment area. BMC Psychiatry. 17(1). 212–212. 26 indexed citations
17.
Aznar‐Lou, Ignacio, Ana Fernández, Marta Fajó‐Pascual, et al.. (2017). Initial medication non‐adherence: prevalence and predictive factors in a cohort of 1.6 million primary care patients. British Journal of Clinical Pharmacology. 83(6). 1328–1340. 34 indexed citations
18.
Aznar‐Lou, Ignacio, Antoni Serrano‐Blanco, Ana Fernández, Juan V. Luciano, & María Rubio-Valera. (2015). Attitudes and intended behaviour to mental disorders and associated factors in catalan population, Spain: cross-sectional population-based survey. BMC Public Health. 16(1). 127–127. 28 indexed citations
19.
Rubio-Valera, María, Maria Teresa Peñarrubia‐María, Rita Fernández‐Vergel, et al.. (2015). Impacto de una intervención farmacéutica en la prevención de recaídas en depresión en atención primaria. Atención Primaria. 48(5). 308–315. 5 indexed citations
20.
Rubio-Valera, María, Ana Fernández, Sara Evans‐Lacko, et al.. (2015). Impact of the mass media OBERTAMENT campaign on the levels of stigma among the population of Catalonia, Spain. European Psychiatry. 31. 44–51. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Siska Desplenter Breakdown of academic impact, for papers by Heather Smith Breakdown of academic impact, for papers by Anne Halli-Tierney Breakdown of academic impact, for papers by Kelly B. Haskard‐Zolnierek Breakdown of academic impact, for papers by Julia R. Liew Breakdown of academic impact, for papers by Linni Gu Breakdown of academic impact, for papers by Papatya Karakurt Breakdown of academic impact, for papers by C. I. Hasanah Breakdown of academic impact, for papers by Confidence M. Gbarayor Breakdown of academic impact, for papers by Camille Cipri
Rankless by CCL
2026